Solara Active News Today : Breaking News, Live Updates & Top Stories | Vimarsana

On Monday, 2025 stocks advanced, 1661 declined and 201 remained unchanged, with an advance decline ratio of 1.22 on the Bombay Stock Exchange (BSE), indicating a positive closing of stocks in broader markets. Strong results in the pharma and IT industries helped the Indian market start the week with modest gains. The market was cautious due to the upcoming release of inflation data and the RBI's monetary policy.

On Monday, 2025 stocks advanced, 1661 declined and 201 remained unchanged, with an advance decline ratio of 1.22 on the Bombay Stock Exchange (BSE), indicating a positive closing of stocks in broader markets. Strong results in the pharma and IT industries helped the Indian market start the week with modest gains. The market was cautious due to the upcoming release of inflation data and the RBI's monetary policy.

After a week filled with better-than-expected quarterly earnings report of giant firms like TVS, HDFC, etc, stock market investors will be keenly waiting for Q4 report of Tata Motors, Canara Bank, HAL, DLF, Vedanta, and others next week

USFDA clears Solara Active's Visakhapatnam facility. The US Food and Drug Administration has cleared Solara Active Pharma Sciences Ltd's new multipurpose active pharmaceutical ingredient manufacturing facility at Visakhapatnam, Andhra Pradesh, with no observation, the company said in an exchange filing.

Global Modest Fashion Weeks Finally arrives in Saudi Arabia and bring a theme